This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reed, B. Y. Articles by Pak, C. Y. C. Search for Related Content PubMed PubMed Citation Articles by Reed, B. Y. Articles by Pak, C. Y. C.

Identification and Characterization of a Gene with Base Substitutions Associated with the Absorptive Hypercalciuria Phenotype and Low Spinal Bone Density

Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8885

Address all correspondence and requests for reprints to: Berenice Y. Reed, Ph.D., Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-8885. E-mail: . berenice.gitomer{at}utsouthwestern.edu

Abstract

Absorptive hypercalciuria (AH) is a kidney stone-forming condition frequently complicated by bone loss. Previously, we mapped the locus for an inherited form of AH to chromosome 1q23.3-q24. We have sequenced a putative gene (subsequently shown by others to be homologous with the rat soluble adenylate cyclase gene) in this region in 12 unrelated Caucasian AH patients. Eighteen base substitutions were identified in the soluble adenylate cyclase human homolog gene. All sequence variations were further evaluated in 3–68 additional unrelated AH patients and 19–132 normal subjects, and 1 additional base substitution was identified. Six of the identified sequence variations occurred with increased frequency in the AH population and tracked with the AH phenotype in AH families. Calculated odds ratios showed that the occurrence of any 4 of these individual base substitutions was associated with a 2.2- to 3.5-fold increase in estimated risk for AH (P < 0.02). In addition, 1 or more base changes was associated with a lower L2–L4 vertebral bone density. Sequence analysis of 3 other genes within the AH linkage interval showed no difference in the distribution of sequence variations between AH and normal populations. This is the first description of a specific gene defect associated with AH.

This article has been cited by other articles:

				M. J. STECHMAN, N. Y. LOH, and R. V. THAKKER Genetics of Hypercalciuric Nephrolithiasis: Renal Stone Disease Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 461 - 484. [Abstract] [Full Text] [PDF]

				A. Schmid, Z. Sutto, M.-C. Nlend, G. Horvath, N. Schmid, J. Buck, L. R. Levin, G. E. Conner, N. Fregien, and M. Salathe Soluble Adenylyl Cyclase Is Localized to Cilia and Contributes to Ciliary Beat Frequency Regulation via Production of cAMP J. Gen. Physiol., July 1, 2007; 130(1): 99 - 109. [Abstract] [Full Text] [PDF]

				A. M. Stessin, J. H. Zippin, M. Kamenetsky, K. C. Hess, J. Buck, and L. R. Levin Soluble Adenylyl Cyclase Mediates Nerve Growth Factor-induced Activation of Rap1 J. Biol. Chem., June 23, 2006; 281(25): 17253 - 17258. [Abstract] [Full Text] [PDF]

				R. R. Hoopes Jr., F. A. Middleton, S. Sen, P. A. Hueber, R. Reid, D. A. Bushinsky, and S. J. Scheinman Isolation and Confirmation of a Calcium Excretion Quantitative Trait Locus on Chromosome 1 in Genetic Hypercalciuric Stone-Forming Congenic Rats J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1292 - 1304. [Abstract] [Full Text] [PDF]

				W. Geng, Z. Wang, J. Zhang, B. Y. Reed, C. Y. C. Pak, and O. W. Moe Cloning and characterization of the human soluble adenylyl cyclase Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1305 - C1316. [Abstract] [Full Text] [PDF]

				M. Bevilacqua, L. J. Dominguez, V. Righini, V. Valdes, R. Toscano, O. Sangaletti, T. Vago, G. Baldi, M. Barrella, and G. Bianchi-Porro Increased Gastrin and Calcitonin Secretion after Oral Calcium or Peptones Administration in Patients with Hypercalciuria: A Clue to an Alteration in Calcium-Sensing Receptor Activity J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1489 - 1494. [Abstract] [Full Text] [PDF]

				O. W. Moe and O. Bonny Genetic Hypercalciuria J. Am. Soc. Nephrol., March 1, 2005; 16(3): 729 - 745. [Abstract] [Full Text] [PDF]

				D G Griffin A review of the heritability of idiopathic nephrolithiasis J. Clin. Pathol., August 1, 2004; 57(8): 793 - 796. [Abstract] [Full Text] [PDF]

				R. R. Hoopes Jr., R. Reid, S. Sen, C. Szpirer, P. Dixon, A. A.J. Pannett, R. V. Thakker, D. A. Bushinsky, and S. J. Scheinman Quantitative Trait Loci for Hypercalciuria in a Rat Model of Kidney Stone Disease J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1844 - 1850. [Abstract] [Full Text] [PDF]

				K. K. Frick and D. A. Bushinsky Molecular Mechanisms of Primary Hypercalciuria J. Am. Soc. Nephrol., April 1, 2003; 14(4): 1082 - 1095. [Full Text] [PDF]

				M. J. Econs and T. Foroud The Genetics of Absorptive Hypercalciuria--A Note of Caution J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1473 - 1475. [Full Text] [PDF]